Table 3

Association between individual characteristics and odds of insulin pump use according to pump funding program status

CharacteristicPump funding program
(n=1320)
No pump funding program
(n=239)
OR (95% CI)OR (95% CI)
Demographic
Age (per 1-year increase)0.97 (0.96 to 0.98)0.97 (0.95 to 1.00)
Sex (male vs female)0.77 (0.62 to 0.96)0.94 (0.55 to 1.58)
Provider age (per 1-year increase)1.00 (0.99 to 1.01)1.04 (1.01 to 1.06)
Provider sex (male vs female)1.15 (0.92 to 1.44)1.12 (0.64 to 1.96)
Clinical
Hypertension0.50 (0.38 to 0.65)0.40 (0.21 to 0.74)
BMI0.98 (0.96 to 1.00)0.97 (0.92 to 1.02)
Depression0.69 (0.55 to 0.87)1.00 (0.55 to 1.83)
Osteoarthritis0.67 (0.43 to 1.02)0.57 (0.31 to 1.03)
Laboratory
HbA1c (per 1% increase)0.96 (0.90 to 1.01)0.89 (0.75 to 1.04)
Creatinine1.00 (1.00 to 1.00)1.00 (0.99 to 1.01)
ACR1.00 (1.00 to 1.00)1.00 (0.99 to 1.00)
Medications
Statin0.54 (0.41 to 0.71)0.61 (0.31 to 1.18)
ACEi/ARB0.55 (0.42 to 0.73)0.41 (0.20 to 0.82)
Risk factors
Smoking status (ref=Current)
 Never1.42 (0.92 to 2.17)
 Past1.31 (0.87 to 1.96)0.67 (0.06 to 7.35)
Alcohol status (ref=Current)
 Never1.55 (0.63 to 3.79)
 Past0.95 (0.64 to 1.39)2.24 (0.33 to 15.17)
Socioeconomic
Income quintile (ref=1)
 21.23 (0.87 to 1.72)1.57 (0.49 to 5.01)
 31.75 (1.25 to 2.46)2.47 (0.89 to 7.15)
 41.67 (1.17 to 2.38)2.33 (0.74 to 7.34)
 5 (highest)1.64 (1.14 to 2.35)1.83 (0.56 to 5.96)
Urban residence (vs rural)1.17 (0.89 to 1.55)0.99 (0.56 to 1.75)
  • ACEi, ACE inhibitor; ACR, albumin-to-creatinine ratio; ARB, angiotensin receptor blocker; BMI, body mass index; HbA1c, hemoglobin A1c.